Mar 02, 2021 8:00am EST Ekso Bionics to Present at the H.C. Wainwright Global Life Sciences Conference
Feb 18, 2021 8:00am EST Ekso Bionics® to Report Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
Feb 08, 2021 11:30pm EST Ekso Bionics Increases Previously Announced Bought Deal Offering of Common Stock to $40 Million
Jan 13, 2021 4:05pm EST Ekso Bionics Reports Preliminary Fourth Quarter and Full Year 2020 Financial Results
Dec 30, 2020 8:00am EST Ekso Bionics’ Stockholders Elect Mary Ann Cloyd and Rhonda A. Wallen to its Board of Directors
Nov 10, 2020 8:00am EST Ekso Bionics Announces Continued Adoption of EVO™ with Flexible Subscription-Based Order from Cloverdale Foods Company
